Effect of Age and Gender on the PK and Tolerability of Finafloxacin
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
Previous clinical studies have indicated that finafloxacin is well-tolerated with few
treatment-related adverse events. As a part of the clinical development of finafloxacin,
other PK studies are required to determine the effect of other variables on the PK profile of
finafloxacin. This study aims to determine the effect of age and gender on the
pharmacokinetic profile of finafloxacin.